Pneumocystis jirovecii Pneumonia in Kidney Transplant Recipients Receiving Belatacept: A Report of Two Cases With Atypical Presentations
Immunosuppressive therapy after kidney transplantation is associated with an increased risk for the development of opportunistic infections, such as Pneumocystis jirovecii pneumonia (PJP). Belatacept, a selective costimulatory blocker that prevents T cell activation, was previously suggested to be a...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2024-10-01
|
| coleção: | Kidney Medicine |
| Assuntos: | |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S259005952400102X |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|